Fisher Asset Management LLC bought a new stake in shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE – Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 2,704,418 shares of the company’s stock, valued at approximately $271,848,000. Fisher Asset Management LLC owned approximately 17.97% of iShares U.S. Pharmaceuticals ETF as of its most recent SEC filing.
Other hedge funds have also recently bought and sold shares of the company. Balance Wealth Partners LLC acquired a new stake in iShares U.S. Pharmaceuticals ETF in the 3rd quarter valued at about $42,000. Russell Investments Group Ltd. grew its stake in shares of iShares U.S. Pharmaceuticals ETF by 148.4% in the 3rd quarter. Russell Investments Group Ltd. now owns 467 shares of the company’s stock worth $47,000 after purchasing an additional 279 shares during the last quarter. Root Financial Partners LLC bought a new stake in shares of iShares U.S. Pharmaceuticals ETF in the 3rd quarter worth approximately $51,000. Congress Asset Management Co. bought a new stake in shares of iShares U.S. Pharmaceuticals ETF in the 3rd quarter worth approximately $56,000. Finally, Trust Co. of Vermont bought a new stake in shares of iShares U.S. Pharmaceuticals ETF in the 2nd quarter worth approximately $60,000.
iShares U.S. Pharmaceuticals ETF Price Performance
IHE stock opened at $110.25 on Friday. iShares U.S. Pharmaceuticals ETF has a 12 month low of $79.82 and a 12 month high of $111.98. The firm has a market cap of $1.71 billion, a PE ratio of 17.75 and a beta of 0.47. The firm has a 50 day simple moving average of $102.97 and a 200 day simple moving average of $95.73.
iShares U.S. Pharmaceuticals ETF Profile
iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.
See Also
- Five stocks we like better than iShares U.S. Pharmaceuticals ETF
- Checkmate for AI Chips? NVIDIA’s Crisis Opens the Board
- Can NVIDIA Maintain Its Momentum Without Huang?
- Six Flags Lost $366 Million in Q3—Its Insiders Just Went Shopping
- What Went Wrong With Amprius Technologies’ Q3? Less Than You’d Think
Want to see what other hedge funds are holding IHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE – Free Report).
Receive News & Ratings for iShares U.S. Pharmaceuticals ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares U.S. Pharmaceuticals ETF and related companies with MarketBeat.com's FREE daily email newsletter.
